Biosimilars Council Calls Out PBMs For Suppressing Humira Biosimilars Adoption
The Association Singled Out The Intermediaries’ In New Data Analysis
The US off-patent association published an analysis of IQVIA data, which highlights the role of rebate schemes that is slowing the adoption of Humira biosimilars that would save billions of dollars.
